Published Studies
   
 
Pedia Research Published Studies

Pedia Research encourages and promotes the publication of the findings from the clinical studies we conduct for the pharmaceutical industry in medical/scientific journals. This is important to the advancement of health care. Below is a list of publications from our studies, several of which the lead authors are Pedia Research investigators.

If you are interested in receiving a printed copy of any study below, please call us at 270.685.4589 or 888.866.8020.
  1. Hamilton T, Menter A, Caro I, Compton P, Sobell J, Papp KA. "Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis An Open-Label Extension of a Phase IIIb Trial." Drug Safety 2008; 31(8):715-726.,

  2. Biederman J, Pliszka SR. "Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents." J Pediatr 2008; 152(3):394-399.

  3. Litov R, Benbow M, Ziegler E. “Growth of Infants Fed Starter Formula Containing Synbiotics.” J Pediatr Gastroenterol Nutr 2007; 44(6):PN1-14.

  4. Ziegler E, Black B, Lessin H, Jones S, Sun S. “Assessment of Growth of Infants Fed a Starter Infant Formula Containing Prebiotics and Probiotics.” Abstract at the annual Pediatric Academic Society, Toronto, 2007.

  5. Berseth CL, Vanderhoof JA, Ferguson PW. “Formula Intolerance in Healthy Infants: Impact of Intact Protein Versus Partially Hydrolyzed 100% Whey.” J Perinatology 2007;27:647.

  6. Berseth CL, Marunycz J, Mitmesser SH. “Discordance in Physician and Parent Perception of Formula Intolerance.” Abstract at the annual North American Society for Pediatric Castroenterology, Hepatology and Nutrition (NASPGHAN), Salt Lake City, 2007.

  7. Litov R, Moore N, Sun S. “Evaluation of Prebiotic Tolerance in Pre-Weaning Infants.” J Pediatr Gastroenterol Nutr 2006; 43(4):E64.

  8. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team. “Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine.” N Engl J Med 2006 ;354:23-33.

  9. Swanson JM, Greenhill LL, Lopez FA, Sedillo A, Earl CQ, Jiang JG, Biederman J. “Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.” J Clin Psychiatry 2006; 67(1):137-147.

  10. Greenhill LL, Sedillo A, Jiang JG, Earl CQ. “Modafinil-ADHD in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD): Efficacy by ADHD Subtype.” Abstract at the annual APA Conference Toronto, 2006.

  11. Arnold V, Rosenthal M, Sedillo A, Earl CQ, Jiang JG. “Modafinil-ADHD Improves Health-Related Quality of Life for 12 Months in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.” Abstract at the annual CHADD Conference Chicago, 2006.

  12. Swanson JM, Greenhill LL, Lopez FA, Sedillo A, Biederman J., Earl CQ, Jiang JG. Modafinil Film-Coated Tablets Demonstrate Early Efficacy in Pediatric Attention-Deficit/Hyperactivity Disorder and Are Not Associated With Withdrawal or Discontinuation Syndrome.” Abstract at the annual NCDEU Conference, Boca Raton, 2006.

  13. Cekola PL and Litov RE. “Electronic Data Capture: Evaluation and Experience of Palm® Technology for Daily Diaries in Infant Nutrition Research.” J Am Diet Assoc 2006; 106(8):A-58.

  14. Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schodel F, Kuter BJ; Consistency Lot Study Group for ProQuad. “The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.” Pediatr Infect Dis J 2006; 25(7):615-622.

  15. Wigal SB, Biederman J, Swanson JM, Yang R, Greenhill LL. "Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies." Prim Care Companion J Clin Psychiatry 2006; 8(6):352-360.

  16. Arnold LE, Patel A, Rugino T, Beckett L, McKay M. “Abrupt Conversion from Oral Methylphenidate to a Transdermal Patch.” Abstract at the annual American Psychiatric Association Meeting, Toronto, 2006.

  17. Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K. “A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.” Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45(3):280-288.

  18. Gelfand EW, Georgitis JW, Noonan M, Ruff ME. “Once-daily ciclesonide in children: efficacy and safety in asthma.” J Pediat 2006; 148(3):377-383.

  19. Pollack M, Kinrys G, Krystal A, McCall V, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R. “Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia.” Poster presented at American College of Neuropsychopharmacology (ACNP), Hollywood, FL, 2006.

  20. Papp KA, Bressinck R, Fretzin S, Goffe B, Kempers S, Gordon KB, Caro I, Walicke PA, Wang X, Menter A, Efalizumab Study Group. “Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial.” Int J Dermatol 2006; 45(5):605-14.

  21. Swanson JM, Greenhill L, Sedillo A, Earl CQ, Jiang JG, Biederman J. “Modafinil-ADHD Improves Parent/Teacher/Clinician Ratings in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) with No Withdrawal or Discontinuation Syndrome Following Abrupt Discontinuation.” Abstract at the annual USPMHC Conference, Las Vegas, 2005.

  22. Shinefield H, Black S, Digilio L, Reisinger K, Blatter M, Gress JO, Hoffman Brown ML, Eves KA, Klopfer SO, Schodel F, Kuter BJ. “Evaluation of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children.” Pediatr Infect Dis J 2005 ;24: 665–669.

  23. Shinefield H, Williams WR, Marchant C, Reisinger K, Stewart T, Meissner C, Guerrero J, Klopfer SO, Schodel F, Kuter BJ, and the Dose Selection Study Group for Proquad. “Dose-Response Study of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children.” Pediatr Infect Dis J 2005 ;24: 670–675.

  24. Langley R, Lebwohl M, Leonardi C, Yeilding N, Guzzo C, Wang Y, Dooley L, Kreuger GG. “Results of a Phase II Study of A Human Anti-Interleukin (IL)-12/IL-23 Monoclonal Antibody in the Treatment of Psoriasis.” Abstract at the annual Society for Investigative Dermatology Meeting, St. Louis, 2005.

  25. Petschow BW, Figueroa R, Harris CL, Beck LB, Zeigler E, Goldin B. “Effects of Feeding an Infant Formula Containing Lactobacillus GG on the Colonization of the Intestine.” J Clin Gastroenterol 2005; 39(9):786-790.

  26. Menter A, Hamilton TK, Caro I, et al. “Safety and tolerability of efalizumab therapy for patients with moderate to severe chronic plaque psoriasis: results of an open-label Phase IIIb multicenter trial.” Abstract at 63rd Annual Meeting of the American Academy of Dermatology, New Orleans, 2005, Poster 2793.

  27. Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE. “A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents.” American Journal of Psychiatry 2004; 161(6):1079-1083.

  28. Stone WL, LeClair I, Ponder T, Baggs G, Barrett-Reis B. “Infants Discriminate Between Natural and Synthetic Vitamin E.” Am J Clin Nutr 2003; 77:899-906.

  29. Lyttle B, Gilles J, Panov M, Emeryk A, Wixon C. “Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children.” J Canadian Thoracic Society 2003; 10 (2):103-109.

  30. Petschow B, Figueroa R, Harris C, Zeigler E, Goldin B, Moran JR, Vanderhoof J. “Comparison of Intestinal Colonization and Tolerance Following Oral Administration of Different Levels of Lactobacillus rhamnosus Strain GG (LGG) in Healthy, Term Infants.” J Pediatr Gastroenterol Nutr 2003; 36(4):566.

  31. Petschow B, Figueroa R, Vanderhoof J,, Zeigler E, Goldin B, Moran JR,. “Intestinal Colonization and Tolerance Among Healthy Infants Fed an Infant Formula Containing Different Levels of Lactobacillus rhamnosus Strain GG (LGG).” Ped Res 2003 ;53:173A.

  32. Papp KA, Sobell J, Toth D, et al. “Safety of subcutaneous efalizumab therapy in patients with moderate to severe plaque psoriasis.” Abstract at the American Academy of Dermatology Summer Meeting, Chicago, 2003.

  33. Nayak A, Lanier R, Weinstein S, Stampone P, Welch M. “Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study. Ches 2002; 122(6):1956-1965.

  34. Borschel MW, Barrett-Reis B, Baggs GE, Williams TA. “Growth of Healthy Term Infants Fed a Powdered Casein Hydrolysate-Based Formula (CHF).” FASEB J 2002 ;16:A661.
Owensboro, KY • Newburgh, IN • Henderson, KY • 270.685.4589 • 888.866.8020

©2008 • Pedia Research, LLC  •  Contact Us  •  Terms & Conditions